Jump to main content
Jump to site search

Issue 13, 2016
Previous Article Next Article

Optimized Rhodamine B labeled mesoporous silica nanoparticles as fluorescent scaffolds for the immobilization of photosensitizers: a theranostic platform for optical imaging and photodynamic therapy

Author affiliations

Abstract

A highly efficient bifunctional mesoporous silica nanodevice coupling optical imaging with photodynamic therapy (PDT) was successfully prepared by using Rhodamine B as a contrast agent and verteporfin as a photosensitizer. The precise localization and high dispersion of the contrast agent in the nanoparticles is the key point to get higher fluorescence quantum yields with respect to the fluorophore in solution. To obtain this information photoluminescence spectroscopy coupled with fluorescence lifetime measurements was used, due to its high sensitivity. The bifunctional nanodevice showed good performances both in terms of quantum yield of the anchored Rhodamine B (ΦRhB = 0.55) and the singlet oxygen delivery efficiency for PDT applications.

Graphical abstract: Optimized Rhodamine B labeled mesoporous silica nanoparticles as fluorescent scaffolds for the immobilization of photosensitizers: a theranostic platform for optical imaging and photodynamic therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 09 Feb 2016, accepted on 27 Feb 2016 and first published on 29 Feb 2016


Article type: Paper
DOI: 10.1039/C6CP00906A
Citation: Phys. Chem. Chem. Phys., 2016,18, 9042-9052
  •   Request permissions

    Optimized Rhodamine B labeled mesoporous silica nanoparticles as fluorescent scaffolds for the immobilization of photosensitizers: a theranostic platform for optical imaging and photodynamic therapy

    B. Martins Estevão, I. Miletto, L. Marchese and E. Gianotti, Phys. Chem. Chem. Phys., 2016, 18, 9042
    DOI: 10.1039/C6CP00906A

Search articles by author

Spotlight

Advertisements